SMS Pharma Shares Jump 17% After USFDA Nod for Ranitidine
SMS Pharmaceuticals shares surged 17% after USFDA approved reformulated Ranitidine tablets. The approval marks the drug's return to US market after 5 years, boosting company's growth prospects.